Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
Navellier & Associates Inc. Acquires Shares of 16,004 Pilgrim’s Pride Co. (NASDAQ:PPC)
Navellier & Associates Inc. bought a new position in shares of Pilgrim’s Pride Co. (NASDAQ:PPC – Free Report) in the...
L & S Advisors Inc Increases Stock Position in iShares Broad USD High Yield Corporate Bond ETF (BATS:USHY)
L & S Advisors Inc grew its position in shares of iShares Broad USD High Yield Corporate Bond ETF (BATS:USHY...
L & S Advisors Inc Invests $1.22 Million in Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS)
L & S Advisors Inc acquired a new position in Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS – Free Report)...
L & S Advisors Inc Grows Holdings in Global X U.S. Preferred ETF (NYSEARCA:PFFD)
L & S Advisors Inc raised its holdings in Global X U.S. Preferred ETF (NYSEARCA:PFFD – Free Report) by 5.4%...
Smithfield Trust Co Purchases 646 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)
Smithfield Trust Co raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 86.1% during the third...
L & S Advisors Inc Has $1.66 Million Holdings in Carpenter Technology Co. (NYSE:CRS)
L & S Advisors Inc lessened its holdings in shares of Carpenter Technology Co. (NYSE:CRS – Free Report) by 33.1%...